Replies to post #2348 on Asensus Surgical Inc (ASXC)

[SPORT19]

SurgiBot will never make it to market
Senhance is a commercial failure in Europe and was not submitted for FDA approval by the end of 2016 as previously announced.
Lincoln Park Capital is a vulture and your stock is being further diluted.
Otherwise your looking good!

[SPORT19]

Enjoy YOUR upcoming raise!!!!
This thing is toast....tried to warn you.
Too bad, so sad.@